Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Assets (2016 - 2025)

Historic Assets for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $6.4 billion.

  • Bruker's Assets rose 526.75% to $6.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 billion, marking a year-over-year increase of 526.75%. This contributed to the annual value of $5.8 billion for FY2024, which is 3663.15% up from last year.
  • Per Bruker's latest filing, its Assets stood at $6.4 billion for Q3 2025, which was up 526.75% from $6.3 billion recorded in Q2 2025.
  • In the past 5 years, Bruker's Assets ranged from a high of $6.4 billion in Q3 2025 and a low of $3.0 billion during Q1 2021
  • For the 5-year period, Bruker's Assets averaged around $4.4 billion, with its median value being $3.8 billion (2023).
  • Per our database at Business Quant, Bruker's Assets plummeted by 104.66% in 2022 and then surged by 6004.03% in 2024.
  • Quarter analysis of 5 years shows Bruker's Assets stood at $3.6 billion in 2021, then dropped by 1.05% to $3.6 billion in 2022, then grew by 17.67% to $4.2 billion in 2023, then surged by 36.63% to $5.8 billion in 2024, then grew by 10.82% to $6.4 billion in 2025.
  • Its Assets stands at $6.4 billion for Q3 2025, versus $6.3 billion for Q2 2025 and $5.9 billion for Q1 2025.